Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Once unheard-of survival rates seen among patients with advanced Merkel cell carcinoma.
Study reveals how blood vessels in the bone marrow protect dormant tumor cells, suggests a way to kill them in their sleep.
Loosening strict comorbidity criteria would open trials to thousands of previously ineligible patients.
New tech is giving scientists unprecedented insights into single cells’ inner workings.
Q&A: Riki Peters, PhD, MPH, on what this large genome-wide association study means for patients and the public
One hundred twenty volunteers to enroll in Seattle-area study of cancer-related gene mutations
First-in-human pilot of experimental immunotherapy in Merkel cell carcinoma
Cancer cells disappeared rapidly in patients with high-risk, treatment-resistant disease.
Ten HIV-positive cancer patients to receive donated cord blood with rare resistance gene.
Myths and misinformation still keep many people in the dark — and that’s bad news for their health.
Phil Greenberg, MD, receives high honor for his contributions to the field.
Advocates, oncologists and researchers share findings, resources and reasons for hope at third annual NW Mets Conference.
The large clinical trial is funded by a $3.5M federal research grant.
Mouse study shows how transplanting patients’ own healthy blood stem cells can curb cancer, opening door to better treatments.
Cancer geneticists, epidemiologists and oncologists team up to use mutation rate to predict individual cancer risk.
How a new technology solved a mystery and honors one man’s legacy
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.